These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 28654015)
1. LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma. Knecht H; Mai S Viruses; 2017 Jun; 9(7):. PubMed ID: 28654015 [TBL] [Abstract][Full Text] [Related]
2. Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells. Knecht H; Johnson NA; Haliotis T; Lichtensztejn D; Mai S Lab Invest; 2017 Jul; 97(7):772-781. PubMed ID: 28436953 [TBL] [Abstract][Full Text] [Related]
3. The Use of 3D Telomere FISH for the Characterization of the Nuclear Architecture in EBV-Positive Hodgkin's Lymphoma. Knecht H; Mai S Methods Mol Biol; 2017; 1532():93-104. PubMed ID: 27873269 [TBL] [Abstract][Full Text] [Related]
4. LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates. Lajoie V; Lemieux B; Sawan B; Lichtensztejn D; Lichtensztejn Z; Wellinger R; Mai S; Knecht H Blood; 2015 Mar; 125(13):2101-10. PubMed ID: 25568351 [TBL] [Abstract][Full Text] [Related]
5. 3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres. Knecht H; Sawan B; Lichtensztejn Z; Lichtensztejn D; Mai S Lab Invest; 2010 Apr; 90(4):611-9. PubMed ID: 20142802 [TBL] [Abstract][Full Text] [Related]
6. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684 [TBL] [Abstract][Full Text] [Related]
7. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317 [TBL] [Abstract][Full Text] [Related]
8. 3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells. Knecht H; Brüderlein S; Mai S; Möller P; Sawan B Ann Anat; 2010 Sep; 192(5):302-8. PubMed ID: 20810259 [TBL] [Abstract][Full Text] [Related]
9. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669 [TBL] [Abstract][Full Text] [Related]
10. Genomic Instability: The Driving Force behind Refractory/Relapsing Hodgkin's Lymphoma. Knecht H; Righolt C; Mai S Cancers (Basel); 2013 Jun; 5(2):714-25. PubMed ID: 24216998 [TBL] [Abstract][Full Text] [Related]
11. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection. García-Cosío M; Santón A; Martín P; Reguero ME; Cristóbal E; Bellas C Histol Histopathol; 2008 Feb; 23(2):209-17. PubMed ID: 17999377 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander. Oudejans JJ; Jiwa NM; Meijer CJ J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428 [TBL] [Abstract][Full Text] [Related]
14. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps". Knecht H; Brüderlein S; Wegener S; Lichtensztejn D; Lichtensztejn Z; Lemieux B; Möller P; Mai S BMC Cell Biol; 2010 Dec; 11():99. PubMed ID: 21144060 [TBL] [Abstract][Full Text] [Related]
15. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease. Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680 [TBL] [Abstract][Full Text] [Related]
16. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma. Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy. Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055 [TBL] [Abstract][Full Text] [Related]
18. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216 [TBL] [Abstract][Full Text] [Related]
19. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Reynolds DJ; Banks PM; Gulley ML Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953 [TBL] [Abstract][Full Text] [Related]
20. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group. Aybar A; Krause JR Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]